GoodRx Holdings (GDRX) reported Q4 adjusted earnings Thursday of $0.09 per diluted share, up from $0.08 a year earlier.
Analysts polled by FactSet expected $0.09.
Revenue for the quarter ended Dec. 31 was $198.6 million, up from $196.6 million a year earlier.
Analysts surveyed by FactSet expected $199.8 million.
The company expects revenue of $201 million to $205 million for Q1 and $810 million to $840 million for 2025. Analysts surveyed by FactSet expect $202.8 million and $825.2 million, respectively.
The company's shares were up 1% in premarket activity Thursday.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。